AllerGen investigator Dr. Bruce Mazer has been designated Interim Executive Director and Chief Scientific Officer (CSO) of the Research Institute of the McGill University Health Centre (RI-MUHC). His appointment will be effective from October 1, 2016, until a new Executive …

Dr. Bruce Mazer named interim head of RI-MUHC Read more »

Dr. Judah Denburg, Scientific Director and CEO of AllerGen, was inducted as a Fellow of the Canadian Academy of Health Sciences (CAHS) at the CAHS Annual General Meeting in Montreal on September 15, 2016. Election to fellowship in the CAHS …

AllerGen’s Scientific Director appointed as Canadian Academy of Health Sciences Fellow Read more »

New research by AllerGen investigators at The University of British Columbia (UBC) has found that a group of immune cells known as Group 3 innate lymphoid cells (ILC3) could be the key to the development of fibrosis in a mouse …

AllerGen researchers find possible key to fibrosis in mouse model of Crohn’s disease Read more »

Health outcomes researcher and AllerGen research collaborator Dr. Mohsen Sadatsafavi has been awarded a New Investigator Salary Award, valued at $300,000 over five years (2016-2021), by the Canadian Institutes of Health Research (CIHR). The award will support Dr. Sadatsafavi’s work …

Mohsen Sadatsafavi receives CIHR New Investigator award Read more »

Dr. Malcolm Sears, an internationally renowned respirologist and epidemiologist, has been named joint winner of the prestigious 2016 J. Allyn Taylor International Prize in Medicine. The Robarts Research Institute of Western University in London, ON, awards the prize annually to …

CHILD Study director awarded J. Allyn Taylor International Prize in Medicine Read more »

Does bullying play a role in a child’s decision whether or not to wear medical identification jewelry for a food allergy? New Canadian research suggests that it does. A study of 110 children and teens with food allergy found that …

Bullying of children with food allergy: its influence on wearing medical identification Read more »

A new study from AllerGen’s Canadian Healthy Infant Longitudinal Development (CHILD) Study is the first to show an association between early gut immune development and colonization with Clostridium difficile (C. difficile)—a bacteria known to be a risk factor for future …

CHILD Study shows link between IgA and C. difficile bacteria Read more »

Dr. Parameswaran Nair has been named the inaugural recipient of the Frederick E. Hargreave Teva Innovation Chair in Airway Diseases at McMaster University. Dr. Nair is Professor of Medicine in the Division of Respirology at McMaster University, a clinician-researcher at …

AllerGen CIC Leader Dr. Parameswaran Nair named Frederick E. Hargreave Teva Innovation Chair in Airway Diseases Read more »

AllerGen investigator Dr. Sonia Anand has received two recent honours: one for her excellence as an international scholar, the other for her efficacy as an advocate for women’s heart health. Dr. Anand was one of two professors from the Faculty …

Dr. Sonia Anand honoured for health advocacy, international scholarship Read more »

New research using data from AllerGen’s Canadian Healthy Infant Longitudinal Development (CHILD) Study has found that children perform better on developmental testing at one year of age if their mothers consume more fruit during pregnancy. AllerGen investigator Dr. Piush Mandhane, …

Prenatal fruit consumption boosts babies’ cognitive development: CHILD Study data Read more »